Medicinal Plants: Their Use in Anticancer Treatment

Area of Science:

• Oncology
• Pharmacology
• Natural Product Chemistry

Background:

• Cancer remains a significant global health burden, driving the need for novel therapeutic strategies.
• Naturally-derived compounds from medicinal plants are increasingly investigated as alternatives to conventional treatments due to potentially lower toxicity.
• The Plant Kingdom is a rich source of secondary metabolites with demonstrated anticancer potential.

Purpose of the Study:

• To review the demand for naturally-derived compounds from medicinal plants for cancer treatment.
• To highlight the properties of these compounds that make them suitable for anticancer drug development.
• To discuss emerging technologies, such as nanoparticles, for enhancing the efficacy of plant-derived anticancer agents.

Main Methods:

• Literature review of scientific and research publications on medicinal plants and cancer therapy.
• Analysis of the chemical properties and biological activities of plant-derived secondary metabolites.
• Exploration of advancements in drug delivery systems, including nano-medicines.

Main Results:

• Medicinal plants provide a viable source for developing new anticancer drugs with potentially reduced side effects.
• Specific plant compounds have shown significant anticancer activities, leading to their incorporation into clinical treatments.
• Emerging technologies like nanoparticles offer new avenues for improving the delivery and efficacy of these natural compounds.

Conclusions:

• There is a growing demand for natural compounds from medicinal plants as a basis for innovative cancer therapies.
• The unique properties of plant-derived metabolites position them as key candidates for future anticancer drug development.
• Integration with new technologies, such as nano-medicine, promises to optimize the therapeutic potential of these natural agents.